Ursodeoxycholic Acid Market, By Type (Branded and Generics), By Dosage Form (Tablets, Capsules, and Oral Suspensions), By Strength (150 mg, 250 mg, 300 mg, and 500 mg), By Indication (Primary Biliary Cholangitis (PBC), Gallstone Dissolution, Cholestatic Liver Diseases, Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Cystic Fibrosis-Associated Liver Disease, and Other Hepatobiliary Disorders), By Age Group (Adult and Pediatric), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
Four thousand five hundred dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
Seven thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10000
Ten thousand dollars
Client Testimonials
Client Testimonials
우리의 고객